Silk Round Fund and INA Invest in Indonesian Pharma Companies
The Chinese state-owned Silk Round Fund (SRF) and Indonesia’s sovereign fund INA have reportedly agreed...
Deals
Hansoh Pharmaceutical Licenses Biotheus’ Bispecific Antibody PM1080 for Greater China
China-based Hansoh Pharmaceutical Group Co., Ltd (HKG: 3692) has announced a licensing agreement with fellow...
Sansure Biotech Partners with UBC to Manufacture in Indonesia
China-based molecular diagnostics specialist Sansure Biotech Inc. (SHA: 688289) has entered into a local manufacturing...
Harbour BioMed and WuXi Biologics Announce Strategic Collaboration
Harbour BioMed (HKG: 2142), a global biotechnology company with operations in the United States, the...
BRL Medicine Raises RMB 200M in Series B Financing for CGT Development
BRL Medicine Inc., a cell and gene therapy (CGT) developer based in Shanghai, has reportedly...
Daxiang Biotech Raises RMB 100M in Pre-Series B Financing for Organoid-on-a-Chip
Beijing-based Daxiang Biotech Co., Ltd., a leading domestic company in the organoid-on-a-chip field, has reportedly...
HitGen Partners with Daewoong Pharmaceutical for Drug Discovery
China-based HitGen Inc. (SHA: 688222) has announced a research collaboration agreement with South Korea’s Daewoong...
AstraZeneca and CICC Capital Launch RMB 3 Billion Fund in Hangzhou
The joint venture (JV) between UK pharmaceutical giant AstraZeneca (AZ, NASDAQ: AZN) and China’s CICC...
Baheal Partners with AstraZeneca for Commercial Rights to Onglyza
China-based health services and distribution giant Baheal Pharmaceutical Group has struck a partnership with AstraZeneca...
Novartis Partners with Alibaba Health to Enhance Patient Medication Accessibility
The 5th China International Import Expo (CIIE) saw the announcement of a partnership between Swiss...
Harbour BioMed and Moderna Ink Licensing Deal for Oncology Immunotherapies
Harbour BioMed (HKG: 2142), a biotech company with operations in the United States, the Netherlands,...
Zenas BioPharma Completes $118M Series B Financing to Advance Obexelimab
Autoimmune disease drug developer Zenas BioPharma, which is based in the US and China, has...
Innovex Medical Files for IPO in Hong Kong to Boost Product Development
Innovex Medical Co., Ltd, a non-vascular interventional surgery solutions provider based in Shanghai, has filed...
GSK Partners with CASPC to Advance HIV Sustained Care Advocacy in China
The 5th China International Import Expo (CIIE) saw the unveiling of a partnership between GlaxoSmithKline...
Boston Scientific Partners with Omron for Atrial Fibrillation Management
US-based Boston Scientific Corporation (NYSE: BSX) has announced a partnership with Japan-based Omron Healthcare at...
Takeda Partners with AWS and Accenture to Launch Innovation Incubator at CIIE
The 5th China International Import Expo (CIIE) saw the announcement of a partnership between Takeda...
Shandong Xinhua and Bayer Announce Strategic Partnership at CIIE
A strategic partnership between China-based Shandong Xinhua Pharmaceutical Co., Ltd (HKG: 0719) and Bayer Consumer...
Medtronic Partners with Shanghai JiaHui Hospital at CIIE
US-based Medtronic Inc. (NYSE: MDT) has announced a partnership with Shanghai JiaHui International Hospital, unveiled...
ChainGen Bio Raises RMB 45M in Angel Round for X-oligo Conjugates Development
ChainGen Bio, a Shanghai-based developer of X-oligo conjugates (XOCs), has reportedly raised RMB 45 million...
Yibao Technology Secures Series A+ Funding to Expand Health Insurance Services
Yibao Technology Co., Ltd, a Shanghai-based service provider for city-level supplementary commercial insurance (“Huiminbao”) schemes,...